BPGAM
TARO

BTG Pactual Global Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

BTG Pactual Global Asset Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,666
Closed -$527K – 211
2015
Q2 		$527K Buy
+3,666
New +$523K 0.03% 146

Other funds holding TARO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
GCM
Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

BTG Pactual Global Asset Management's TARO Position: Q3 2015 in Review

BTG Pactual Global Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2015, closing a stake of 3,666 shares — an estimated $527K sold.

BTG Pactual Global Asset Management first reported a position in TARO in Q2 2015 and held it in 1 quarter. The position peaked at $527K in Q2 2015. 121 funds tracked by Wall St. Rank hold TARO as of Q3 2015.

  • BTG Pactual Global Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2015 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 3,666 Taro Pharmaceutical Industries Ltd. shares in Q3 2015, an estimated $527K.
  • BTG Pactual Global Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2015 and held it in 1 quarter.
  • BTG Pactual Global Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $527K in Q2 2015.
  • 121 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2015.

Based on BTG Pactual Global Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.